Morrison D C, Jacobs D M
Infect Immun. 1976 Jan;13(1):298-301. doi: 10.1128/iai.13.1.298-301.1976.
Treatment of bacterial lipopolysaccharides (endotoxins) isolated from Salmonella minnesota R595 or purified lipid A with the antibiotic polymyxin B has been demonstrated to abrogate the ability of these molecules to activate serum complement. The inhibition is a function of the ratio of polymyxin B to lipopolysaccharide.
已证明,用抗生素多粘菌素B处理从明尼苏达沙门氏菌R595分离出的细菌脂多糖(内毒素)或纯化的脂质A,可消除这些分子激活血清补体的能力。这种抑制作用是多粘菌素B与脂多糖比例的函数。